Stereotactic body radiation therapy use for high risk prostate cancer in the United States
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5608
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Stereotactic body radiation therapy use for high risk prostate cancer in the United States ; day:13 ; month:11 ; year:2020 ; pages:1-4
Prostate cancer and prostatic diseases ; (13.11.2020), 1-4
- Creator
-
Patel, Sagar A.
Switchenko, Jeffrey M.
Kishan, Amar U.
Jani, Ashesh B.
Royce, Trevor J.
Fischer-Valuck, Benjamin W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41391-020-00300-5
- URN
-
urn:nbn:de:101:1-2020122423102770296689
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patel, Sagar A.
- Switchenko, Jeffrey M.
- Kishan, Amar U.
- Jani, Ashesh B.
- Royce, Trevor J.
- Fischer-Valuck, Benjamin W.
- SpringerLink (Online service)
Other Objects (12)
Proctitis following stereotactic body radiation therapy for prostate cancer
Stereotactic body radiation therapy
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer
Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
Stereotactic body radiotherapy for organ-confined prostate cancer
Proctitis following stereotactic body radiation therapy for prostate cancer
Stereotactic body radiation therapy
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer
Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
Stereotactic body radiotherapy for organ-confined prostate cancer
Proctitis following stereotactic body radiation therapy for prostate cancer
Stereotactic body radiation therapy
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer
Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI